Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1.
about
Novel xylan-controlled delivery of therapeutic proteins to inflamed colon by the human anaerobic commensal bacteriumTreatment of dextran sodium sulfate-induced experimental colitis by adoptive transfer of peritoneal cells.Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel diseaseThe microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain.The gut microbiota-a clinical perspective on lessons learned.Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.Microbiome therapeutics - Advances and challenges.Polysaccharide Utilization Loci: Fueling Microbial Communities.Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.TGF-beta signaling-dependent alleviation of dextran sulfate sodium-induced colitis by mesenchymal stem cell transplantation.Intracolonically administered adeno-associated virus-bone morphogenetic protein-7 ameliorates dextran sulphate sodium-induced acute colitis in rats.Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.Synthetic Biology and the Gut Microbiome.Pilot Safety Evaluation of a Novel Strain of
P2860
Q34344893-1AE26AB1-FF22-4F55-A62E-3E4D56081639Q36275547-74BCD807-2AEA-45E7-AF19-D61E5D854C9FQ37053638-D90D5926-2523-4BA5-9282-E6BF041433A5Q38031936-AEA7AC33-42E5-412A-B1EB-B8EB4F7EDCC4Q38034375-59B91C36-5EA5-4B23-A795-B24A8F15F1EAQ38049367-448FFBB3-2D2D-4339-8125-FC9701EF8713Q38829360-AF0FA90F-7A1D-49A2-AAFE-CA75C8214770Q39110296-D447AF40-1278-4B7F-9302-38E14C1917B1Q41981077-0922E18A-F60A-4831-9A92-4734CD3B9449Q43736820-7E563733-E8D6-430F-BEE5-2973938C0B61Q44073977-2E4A9154-1ECF-4631-AAC9-7A01838FD7D3Q47818880-D2BEE6D4-516A-46E4-B0BB-0C272B1264DFQ47915556-539E9A06-512C-46D1-88D7-3C707BC23E45Q59128054-B92E3111-04C7-48D8-8EF5-A2479307FE95
P2860
Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Treatment of colitis with a co ...... he control of dietary xylan 1.
@en
Treatment of colitis with a co ...... he control of dietary xylan 1.
@nl
type
label
Treatment of colitis with a co ...... he control of dietary xylan 1.
@en
Treatment of colitis with a co ...... he control of dietary xylan 1.
@nl
prefLabel
Treatment of colitis with a co ...... he control of dietary xylan 1.
@en
Treatment of colitis with a co ...... he control of dietary xylan 1.
@nl
P2093
P2860
P356
P1476
Treatment of colitis with a co ...... he control of dietary xylan 1.
@en
P2093
J Peter A Lodge
Keith T Holland
Meenu Wadhwa
Nigel Scott
Paula Dilger
Robin Thorpe
Terence R Whitehead
Zaed Z R Hamady
P2860
P304
P356
10.1002/IBD.21565
P577
2010-12-17T00:00:00Z